NeuroPace Inc (NAS:NPCE)
$ 7.53 -0.07 (-0.92%) Market Cap: 216.62 Mil Enterprise Value: 232.78 Mil PE Ratio: 0 PB Ratio: 15.23 GF Score: 55/100

Neuropace Inc at Needham Healthcare Conference (Virtual) Transcript

Apr 17, 2023 / 02:15PM GMT
Release Date Price: $4.76 (-0.83%)
Mike Matson
Needham & Company, LLC - Analyst

Good morning. Thanks for joining us again at the 22nd Annual Needham Healthcare Conference. I'm Mike Matson, and I lead the medtech and diagnostics equity research team at Needham & Company.

I'm pleased to introduce NeuroPace. Presenting from NeuroPace is CEO Mike Favet and CFO Rebecca Kuhn. Mike is going to give a presentation -- Mike and Rebecca, excuse me, are going to give a presentation on NeuroPace. And then we should have some time for questions.

If you do have a question that you would like me to ask, you can submit them electronically through the Needham conference website. Or you could feel free to email them to me at [email protected], and I'll do my best to fit them in.

So with that, I'll turn it over to Mike. Thanks.

Mike Favet
NeuroPace, Inc. - CEO & Board Member

Good morning, everyone. Mike, thank you for the opportunity to be able to present this morning. For those of you who haven't been familiar with NeuroPace, I'm going to go over an overview of the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot